白内障术后抗炎药物与后囊膜混浊的关系
该回顾性注册研究分析了2014至2018年芬兰赫尔辛基大学医院25818例连续白内障手术患者,比较术后局部激素、非甾体抗炎药(NSAIDs)或其联合治疗对Nd:YAG激光后囊切开率的影响。
要点
- 白内障术后激素单药较NSAIDs单药显著降低Nd:YAG后囊切开率。
- 激素联合NSAIDs较激素单药无额外获益。
- 多因素校正后激素治疗仍与较低后囊切开率独立相关(HR 0.70)。
核心结论
- 无并发症白内障术后激素治疗较NSAIDs单药与更低临床显著后囊膜混浊率相关。
- 激素联合NSAIDs较激素单药无额外获益。
研究设计与样本
- 回顾性注册队列研究,分析2014至2018年芬兰赫尔辛基大学医院25818例连续白内障手术患者,最终纳入13368例,每例纳入单眼。
- 比较术后局部激素单药、NSAIDs单药或联合治疗组间Nd:YAG激光后囊切开率,采用Kaplan-Meier和Cox回归分析。
主要发现
- 纳入患者平均年龄73.2±9.7岁,女性占61.7%,假性剥脱占10.1%,平均随访22.8±15.7个月。
- 激素单药治疗占28.9%,NSAIDs单药占62.2%,联合治疗占8.9%。
临床怎么用
- 对于无并发症白内障术后患者,选择局部激素单药抗炎可能较NSAIDs单药降低临床显著后囊膜混浊风险。
- 联合激素与NSAIDs较激素单药无额外降低后囊切开率的获益。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To assess the role of anti-inflammatory medication following cataract surgery on the formation of posterior capsular opacification. DESIGN: Cohort study. METHODS: A retrospective registry analysis of 25,818 consecutive patients who underwent cataract surgery between the years 2014 and 2018 at Helsinki University Hospital in Finland. Nd:YAG laser capsulotomy rates were compared between patients treated postoperatively with topical steroids, nonsteroidal anti-inflammatory medications (NSAIDs), or their combination. Kaplan-Meier and Cox regression analyses were used. A single eye of each patient was included. Main outcomes were confirmed against a second independent dataset. RESULTS: A total of 13,368 patients were included in the analysis, with a mean age of 73.2 ± 9.7 years; 61.7% were female. Pseudoexfoliation was noted in 10.1% of cases. The mean follow-up time was 22.8 ± 15.7 months. Patients were treated with steroid monotherapy (28.9% of cases), NSAID monotherapy (62.2%), or a combination of both (8.9%). Treatment with steroids resulted in significantly lower Nd:YAG capsulotomy rates compared to NSAIDs (hazard ratio [HR] 0.76, 95% confidence interval [CI] 0.62-0.93, P = .009). Treatment with combination therapy of steroids and NSAIDs showed no added benefit over steroid monotherapy (HR 1.11, 95% CI 0.68-1.80, P = .674). Cox regression analysis adjusted for patients' age, sex, pseudoexfoliation, and risk stratification remained significantly predictive for lower capsulotomy rates with steroid treatment over NSAIDs (HR 0.70, 95% CI 0.52-0.88, P = .001). CONCLUSIONS: Postoperative treatment with steroids among patients undergoing uncomplicated cataract surgery was associated with lower rates of clinically significant posterior capsule opacification compared to treatment with NSAIDs alone. Combination therapy of steroids and NSAIDs had no added benefit over steroids alone.
引用
- Hecht I, Karesvuo P, Achiron A, et al. Anti-inflammatory Medication After Cataract Surgery and Posterior Capsular Opacification. Am J Ophthalmol. 2020. PMID: 32061757. doi:10.1016/j.ajo.2020.02.007
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。